Skip to Main Content

Paper Details

HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer.
Cell Rep
69
2020
GATA6, GSK3, HNF4A, PDAC, PDCLs, Pancreatic Cancer, Pancreatic ductal adenocarcinoma, chromatin, endodermal lineage, glycogen synthase kinase 3 beta (GSK3, patient, squamous, squamous patient-derived cell lines, squamous subtype
Author NameAffiliation
Robert BrownImperial College London
Gloria M PetersenMayo Clinic
Alan AshworthCRUK Gene Function Laboratory and Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, UK UCSF Helen Diller Family Comprehensive Cancer Center
Sean M GrimmondUniversity of Melbourne Centre for Cancer Research, University of Melbourne
Sean M GrimmondUniversity of Melbourne Centre for Cancer Research, University of Melbourne
  • 1 - 5

Datasets

Release 1.2